Axial SpondyloarthritisPaxSpANCT04679649
Physiotherapy of Axial Spondyloarthritis
A study testing Manual spinal mobilisation physiotherapy in people with Axial Spondyloarthritis, run by Royal United Hospitals Bath NHS Foundation Trust at 2 sites in United Kingdom.
Trial summary
This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a Trials within Cohort (TwiCs) design. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Axial Spondyloarthritis
- What is being tested?
- Manual spinal mobilisation physiotherapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 6 Oct 2021to 30 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patients > 18 years of age from the RUH Bath National Health Service (NHS) Foundation Trust Rheumatology service based at RNHRD who fulfil the modified New York Criteria or the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis criteria giving written consent for participation.
Who cannot join
- Mechanical spinal disease causing red flag symptoms such as cauda equina syndrome
- Age >70
- Pregnancy or breastfeeding
- Any malignancy
- Moderate coexistent other inflammatory conditions (such as rheumatoid arthritis, vasculitis or connective tissue disease, in order to minimise the effect particularly of inflammation). However clinical judgement might be used to judge the severity in some patients as to whether they are safe to be included in a trial.
- Any bridging syndesmophytes in the spine, to avoid the risk of causing vertebral fractures or instability
Trial locations and contacts
2 sites in 1 country.
United Kingdom2 sites
Royal National Hospital for Rheumatic Diseases (RNHRD)
Bath, Wiltshire, BA1 3NG
Sports Physiotherapy Calne
Calne, UK, SN11 9PR
About this study
Official title: Physiotherapy of Axial Spondyloarthritis - PaxSpA Trial A: Manual Spinal Mobilisation in Patients With Axial Spondyloarthritis
This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a Trials within Cohort (TwiCs) design. This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA.
The investigators are seeking to improve outcomes for these patients by comparing different physiotherapy interventions in subsequent trials with standard of care (SoC) physiotherapy. Trial A will compare routine care vs routine care plus MSM physiotherapy attempting to answer the primary research question if MSM on patients with axSpA improves spinal mobility.
In order to recruit patients and obtain outcomes for Trial A (n=70), the investigators will first recruit up to 300 axSpA patients receiving care at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath into a cohort and observe their standard of care outcomes. This will allow to answer the cohort's research question of "How does SoC physiotherapy in patients with axSpA reflect in data collected routinely on outcomes of the disease?" Patients will be asked to consent to provide routine observational data on their wellbeing, be approached to take part in future trials of interventions which aim to improve outcomes for patients with axSpA, and not be approached unless they are offered the physiotherapy trial intervention. This highly pragmatic method of providing information and seeking consent replicates the informed consent procedures in routine care clinical settings. This study is aimed to last three years, with individual trials of 40-70 participants, ranging between three to six months duration of therapy intervention in addition to routine care.
Read the detailed description
A single pragmatic randomised controlled clinical trial (RCT) (Trial A) which is embedded in a series of pragmatic trials within the Trials within Cohort (TwiCs) design of the PaxSpA study. This trial will compare manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA) to routine care alone.This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA. The cohort might seem as an unnecessary add-on to what could be conducted as a standalone standardised RCT, but it has a few important advantages. By having a cohort the investigators can observe routine care physiotherapy outcomes for a large cohort giving data from a large number of patients. That data can be used to compare to across a range of interventions, as each embedded trial will use the same outcome measures and therefore results are comparable across trials to give a broader view of the care of this chronic progressive condition - axial Spondyloarthritis. The other advantage for having for having the cohort is to be able to have a control group receiving standard of care without having disappointment bias for not being in the intervention arm, as physiotherapy interventions can be very difficult to blind participants. The investigators plan to establish an observational cohort of 300 patients with axial spondyloarthritis (axSpA) currently treated at the RUH NHS Trust in Bath and observe their outcomes over the duration of the study, as a cornerstone for our "Trials within cohort" (TwiCs) study PaxSpA. Cohort patients will be asked to consent to (i) provide observational data on their wellbeing (standard routine axSpA PROM), (ii) be approached to take part in future trials of interventions which aim to improve outcomes for patients axSpA, and (iii) not be approached unless they are offered an experimental (i.e. non routine) intervention. Post randomisation, only those randomly selected to an experimental (non-routine) intervention will informed about the experimental interventions and asked for their 'clinical' consent to receive these intervention (i.e. Trial A: manual mobilisation). This method is known as the Trials within Cohorts (TwiCs) method and is currently being used in over 70 studies worldwide, including many in the United Kingdom (UK) and Canada. This method of providing information and seeking consent replicates the informed consent procedures in routine care and has several benefits. Firstly, it avoids unnecessary expectation and disappointment regarding the experimental interventions. Secondly, clinicians do not have to spend time explaining interventions to patients who will not be offered the intervention post randomisation. Thirdly, it enables fast and efficient recruitment to both trials.
The investigators will then conduct the first of possibly several embedded pragmatic randomised controlled trials of adjunctive physiotherapy for patients with axSpA: Trial A will compare routine care vs routine care plus manual spinal mobilisation physiotherapy. The hypothesis for trial A assumes manual spinal mobilisation will improve function, decrease pain and decrease disease activity, but primarily increase spinal mobility, as shown in previous trials to be the case when specific parts of the spine received manual mobilisation.
The study design and methodology has been chosen because of its highly pragmatic character in a clinical setting of a chronic condition. Physiotherapy in axSpA consists of a variety of treatment options to research and outcomes for each intervention can be compared to the routinely taken outcome measures across the cohort to identify and compare benefits/challenges of different interventions. The TwiCs design has been shown to be particularly suitable for chronic conditions, where different treatments are provided to inform clinical practice, and therefore the investigators identified this design to be best suited to meet the aims and objectives our study (also see second paragraph above).
The justification for including control arms to a trial:
The control arm is important for comparison of outcomes and to increase the validity of our study. The control arm will receive standard of care as usual (as will the intervention group), without the additional intervention, therefore the difference in results between the groups will indicate the effect of the trial intervention, enabling to inform clinical practice. Additionally, it is very challenging to blind participants and researcher to physiotherapy interventions, so randomisation with a control group gives our study a sound methodology.
Randomisation will be achieved my random computer allocation in a staged (phased) randomisation process. Initially all cohort participants will get screened for eligibility for trial A and if successful, included into the eligible trial cohort. For trial A the investigators aim to recruit 12 participants per stage/batch into the manual mobilisation trial for six batches (up to 70 participants). For each batch, six participants will get randomly selected from the eligible trial cohort to be offered to receive the intervention. The remaining six participants that were not selected will function as controls. On average the investigators will aim to recruit a new batch every two weeks to start the initially more frequent intervention (from biweekly to monthly over six months) in stages. Therefore, all participants should have been randomised and started the trial within the first 3-4 months of the start of the trial. This phased randomisation/ recruitment to the trial is a due to limited resources and time restraints.
- Conditions
- Axial Spondyloarthritis
- Being tested
- Manual spinal mobilisation physiotherapy
- Keywords
- physiotherapy, manual mobilisation, axial spondyloarthritis
- Medical subject headings
- Axial Spondyloarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Manual spinal mobilisation physiotherapyOther
Also called "Maitland's" mobilisations
Manual spinal mobilisation is a physiotherapy technique to improve spinal mobility by gently applying pressure manually on the each segmental vertebrae by hands-on treatment of a physiotherapist.
| Study group | Role | What they receive |
|---|---|---|
| Trial A - Intervention Group (manual mobilisation) | Experimental | Participants will continue to receive routine care and 13 sessions of manual spinal mobilisation will be administered over a 6 months period to compare routine care vs routine care plus manual spine mobilisation physiotherapy. Receives: Other: Manual spinal mobilisation physiotherapy |
| Trial A - Control Group (routine care) | No intervention | Participants in control group will continue to receive routine care, and routine care measurements for axial spondyloarthritis will be taken at baseline, 3 months and 6 months plus follow up. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of Spinal Mobility
Spinal mobility will be measured using inertial measurement unit sensors; Electro muscle stimulation (EMS) for muscle activity
Measured: baseline, 6 months, and follow-up at 12 months
Change of Spinal Mobility
Spinal mobility will be measured using the Bath Ankylosing Spondylitis Metrology Index (BASMI), scored on the mean of 5 items out of 0-10 (minimum value 0 maximum value 10), '0' being the best outcome and 10 being the worst outcome.
Measured: baseline, 3 months & 6 months, and follow-up at 12 months
Secondary outcomes (5)
Change of Disease Activity
Disease activity using BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) scored on the mean of 6 items out of 0-10 (minimum value 0, maximum value 10), '0' being the best outcome and 10 being the worst outcome.
Measured: baseline, 3 month, 6 month, 12 month
Change of Functional limitation
Functional limitation is measured using BASFI (Bath Ankylosing Spondylitis Functional Index) scored on the mean of 10 items out of 0-10 (minimum value 0, maximum value 10), '0' being the best outcome and 10 being the worst outcome.
Measured: baseline, 3 month, 6 month, 12 month
Change of Quality of Sleep (PROM)
measured using the Jenkins Sleep Evaluation Questionnaire (JSEQ) PROM The JSEQ is a 4-item self-report questionnaire designed to measure how often a subject has experienced sleep problems in the past month. JSEQ items evaluate trouble falling asleep, staying asleep, waking up several times, and awakening unrefreshed with each item scored on a 5-point Likert scale from 0 = "not at all" to 5 = "22-31 days." Scores vary from 0 to 20 with higher scores indicating more frequent sleep problems (worse outcome) and lower scores indicate a better outcome.
'0' being the best outcome and 10 being the worst outcome.
Measured: baseline, 3 month, 6 month, 12 month
Change of Quality of Life (PROM)
measured using the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL). Each statement on the ASQoL is given a score of "1" or "0". A score of "1" is given where the item is affirmed, indicating adverse QoL. All item scores are summed to give a total score or index. Scores can range from 1 (good QoL outcome) to 18 (poor QoL outcome).
Measured: baseline, 3 month, 6 month, 12 month
Change of Work Productivity (PROM)
measured using the Work Productivity and Activity Impairment Questionnaire (WPAI). WPAI scores are based on 1-item (presentism, activity impairment), 2-items (absenteeism) and multiple items (overall work productivity); a score cannot be calculated if there is a missing response to the corresponding item. The WPAI-GH consists of six questions: 1 = currently employed; 2 = hours missed due to health problems; 3 = hours missed other reasons; 4 = hours actually worked; 5 = degree health affected productivity while working (using a 0 to 10 Visual Analogue Scale (VAS)); 6 = degree health affected productivity in regular unpaid activities (VAS).scores are expressed in percentage (0-100) with a lower percentage indicating a better outcome and higher percentage indicating a worse outcome.
Measured: baseline, 3 month, 6 month, 12 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2020
- Study start6 Oct 2021
- Primary completion20 Jun 2022
- Study completion30 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Axial SpondyloarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Pragmatic randomised controlled clinical trial (RCT) with secondary element of observational cohort trial in line with the "Trials within Cohort design" (TwiCs). Trial A is Manual mobilisation of the spine.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Royal United Hospitals Bath NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jane Carter, Study director, Royal United Hospitals Bath NHS FT
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04679649
- Sponsor's protocol ID
- PaxSpA V5 28072020
- Acronym
- PaxSpA
- Status last verified
- Apr 2024
- First submitted
- 16 Nov 2020
- Last updated
- 16 May 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Dr Sengupta has established a national and international panel of collaborators in the field of axial spondyloarthritis. We will therefore try to maintain our links with other experts in the field who are conducting cutting edge research in axSpA. Thus, the data collected as part of this study may be used in further research. Anonymised data may be shared with other researchers investigating non-pharmaceutical therapies in spondyloarthropathy. Requests for data would be evaluated on the basis of the research objectives of the intended project and any conflict of interests involved. If approved, recipients of data must forward copies of their protocol and ethics approval if appropriate to Dr Sengupta and the sponsor (RUH Bath NHS Foundation Trust Rheumatology service based at the RNHRD).
Study at a glance
From the registry record, last updated by the sponsor on 16 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physiotherapy of Axial Spondyloarthritis - PaxSpA Trial A: Manual Spinal Mobilisation in Patients With Axial Spondyloarthritis
- ClinicalTrials.gov ID
- NCT04679649
- Acronym / sponsor ID
- PaxSpA / PaxSpA V5 28072020
- Conditions
- Axial Spondyloarthritis
- Keywords
- physiotherapy, manual mobilisation, axial spondyloarthritis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Royal United Hospitals Bath NHS Foundation TrustUniversity, hospital or other
- Study start
- 6 Oct 2021 (actual)
- Primary completion
- 20 Jun 2022 (actual)
- Study completion
- 30 Jul 2022 (actual)
- First posted
- 22 Dec 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a Trials within Cohort (TwiCs) design. This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA.
The investigators are seeking to improve outcomes for these patients by comparing different physiotherapy interventions in subsequent trials with standard of care (SoC) physiotherapy. Trial A will compare routine care vs routine care plus MSM physiotherapy attempting to answer the primary research question if MSM on patients with axSpA improves spinal mobility.
In order to recruit patients and obtain outcomes for Trial A (n=70), the investigators will first recruit up to 300 axSpA patients receiving care at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath into a cohort and observe their standard of care outcomes. This will allow to answer the cohort's research question of "How does SoC physiotherapy in patients with axSpA reflect in data collected routinely on outcomes of the disease?" Patients will be asked to consent to provide routine observational data on their wellbeing, be approached to take part in future trials of interventions which aim to improve outcomes for patients with axSpA, and not be approached unless they are offered the physiotherapy trial intervention. This highly pragmatic method of providing information and seeking consent replicates the informed consent procedures in routine care clinical settings. This study is aimed to last three years, with individual trials of 40-70 participants, ranging between three to six months duration of therapy intervention in addition to routine care.
Detailed description
A single pragmatic randomised controlled clinical trial (RCT) (Trial A) which is embedded in a series of pragmatic trials within the Trials within Cohort (TwiCs) design of the PaxSpA study. This trial will compare manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA) to routine care alone.This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA. The cohort might seem as an unnecessary add-on to what could be conducted as a standalone standardised RCT, but it has a few important advantages. By having a cohort the investigators can observe routine care physiotherapy outcomes for a large cohort giving data from a large number of patients. That data can be used to compare to across a range of interventions, as each embedded trial will use the same outcome measures and therefore results are comparable across trials to give a broader view of the care of this chronic progressive condition - axial Spondyloarthritis. The other advantage for having for having the cohort is to be able to have a control group receiving standard of care without having disappointment bias for not being in the intervention arm, as physiotherapy interventions can be very difficult to blind participants. The investigators plan to establish an observational cohort of 300 patients with axial spondyloarthritis (axSpA) currently treated at the RUH NHS Trust in Bath and observe their outcomes over the duration of the study, as a cornerstone for our "Trials within cohort" (TwiCs) study PaxSpA. Cohort patients will be asked to consent to (i) provide observational data on their wellbeing (standard routine axSpA PROM), (ii) be approached to take part in future trials of interventions which aim to improve outcomes for patients axSpA, and (iii) not be approached unless they are offered an experimental (i.e. non routine) intervention. Post randomisation, only those randomly selected to an experimental (non-routine) intervention will informed about the experimental interventions and asked for their 'clinical' consent to receive these intervention (i.e. Trial A: manual mobilisation). This method is known as the Trials within Cohorts (TwiCs) method and is currently being used in over 70 studies worldwide, including many in the United Kingdom (UK) and Canada. This method of providing information and seeking consent replicates the informed consent procedures in routine care and has several benefits. Firstly, it avoids unnecessary expectation and disappointment regarding the experimental interventions. Secondly, clinicians do not have to spend time explaining interventions to patients who will not be offered the intervention post randomisation. Thirdly, it enables fast and efficient recruitment to both trials.
The investigators will then conduct the first of possibly several embedded pragmatic randomised controlled trials of adjunctive physiotherapy for patients with axSpA: Trial A will compare routine care vs routine care plus manual spinal mobilisation physiotherapy. The hypothesis for trial A assumes manual spinal mobilisation will improve function, decrease pain and decrease disease activity, but primarily increase spinal mobility, as shown in previous trials to be the case when specific parts of the spine received manual mobilisation.
The study design and methodology has been chosen because of its highly pragmatic character in a clinical setting of a chronic condition. Physiotherapy in axSpA consists of a variety of treatment options to research and outcomes for each intervention can be compared to the routinely taken outcome measures across the cohort to identify and compare benefits/challenges of different interventions. The TwiCs design has been shown to be particularly suitable for chronic conditions, where different treatments are provided to inform clinical practice, and therefore the investigators identified this design to be best suited to meet the aims and objectives our study (also see second paragraph above).
The justification for including control arms to a trial:
The control arm is important for comparison of outcomes and to increase the validity of our study. The control arm will receive standard of care as usual (as will the intervention group), without the additional intervention, therefore the difference in results between the groups will indicate the effect of the trial intervention, enabling to inform clinical practice. Additionally, it is very challenging to blind participants and researcher to physiotherapy interventions, so randomisation with a control group gives our study a sound methodology.
Randomisation will be achieved my random computer allocation in a staged (phased) randomisation process. Initially all cohort participants will get screened for eligibility for trial A and if successful, included into the eligible trial cohort. For trial A the investigators aim to recruit 12 participants per stage/batch into the manual mobilisation trial for six batches (up to 70 participants). For each batch, six participants will get randomly selected from the eligible trial cohort to be offered to receive the intervention. The remaining six participants that were not selected will function as controls. On average the investigators will aim to recruit a new batch every two weeks to start the initially more frequent intervention (from biweekly to monthly over six months) in stages. Therefore, all participants should have been randomised and started the trial within the first 3-4 months of the start of the trial. This phased randomisation/ recruitment to the trial is a due to limited resources and time restraints.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Pragmatic randomised controlled clinical trial (RCT) with secondary element of observational cohort trial in line with the "Trials within Cohort design" (TwiCs). Trial A is Manual mobilisation of the spine.
| Arm | Type | Receives |
|---|---|---|
| Trial A - Intervention Group (manual mobilisation) | Experimental | Other: Manual spinal mobilisation physiotherapyParticipants will continue to receive routine care and 13 sessions of manual spinal mobilisation will be administered over a 6 months period to compare routine care vs routine care plus manual spine mobilisation physiotherapy. |
| Trial A - Control Group (routine care) | No intervention | –Participants in control group will continue to receive routine care, and routine care measurements for axial spondyloarthritis will be taken at baseline, 3 months and 6 months plus follow up. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Adult patients > 18 years of age from the RUH Bath National Health Service (NHS) Foundation Trust Rheumatology service based at RNHRD who fulfil the modified New York Criteria or the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis criteria giving written consent for participation.
Key exclusion criteria (6 listed)
- Mechanical spinal disease causing red flag symptoms such as cauda equina syndrome
- Age >70
- Pregnancy or breastfeeding
- Any malignancy
- Moderate coexistent other inflammatory conditions (such as rheumatoid arthritis, vasculitis or connective tissue disease, in order to minimise the effect particularly of inflammation). However clinical judgement might be used to judge the severity in some patients as to whether they are safe to be included in a trial.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Manual spinal mobilisation physiotherapyAlso: "Maitland's" mobilisationsManual spinal mobilisation is a physiotherapy technique to improve spinal mobility by gently applying pressure manually on the each segmental vertebrae by hands-on treatment of a physiotherapist. | Other | Trial A - Intervention Group (manual mobilisation) |
Primary outcome
Change of Spinal Mobility
Time frame: baseline, 6 months, and follow-up at 12 months
Spinal mobility will be measured using inertial measurement unit sensors; Electro muscle stimulation (EMS) for muscle activity
Change of Spinal Mobility
Time frame: baseline, 3 months & 6 months, and follow-up at 12 months
Spinal mobility will be measured using the Bath Ankylosing Spondylitis Metrology Index (BASMI), scored on the mean of 5 items out of 0-10 (minimum value 0 maximum value 10), '0' being the best outcome and 10 being the worst outcome.
5 secondary outcomes
Change of Disease Activity
Time frame: baseline, 3 month, 6 month, 12 month
Change of Functional limitation
Time frame: baseline, 3 month, 6 month, 12 month
Change of Quality of Sleep (PROM)
Time frame: baseline, 3 month, 6 month, 12 month
Change of Quality of Life (PROM)
Time frame: baseline, 3 month, 6 month, 12 month
Change of Work Productivity (PROM)
Time frame: baseline, 3 month, 6 month, 12 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 May 2024.
- Individual participant dataSharing planned: Yes. Dr Sengupta has established a national and international panel of collaborators in the field of axial spondyloarthritis. We will therefore try to maintain our links with other experts in the field who are conducting cutting edge research in axSpA. Thus, the data collected as part of this study may be used in further research. Anonymised data may be shared with other researchers investigating non-pharmaceutical therapies in spondyloarthropathy. Requests for data would be evaluated on the basis of the research objectives of the intended project and any conflict of interests involved. If approved, recipients of data must forward copies of their protocol and ethics approval if appropriate to Dr Sengupta and the sponsor (RUH Bath NHS Foundation Trust Rheumatology service based at the RNHRD).
Related trials for Axial Spondyloarthritis
Active, not recruiting
Effects of Resistance Exercise on Enthesitis in Patients With Spondyloarthritis
Spondyloarthritis (SpA), Axial Spondylarthritis (axSpA)
RecruitingPhase 1
A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight Subjects; and Pharmacokinetics at Different Subcutaneous Injection Sites at the Same Dose
Psoriasis, Ankylosing Spondylitis
RecruitingPhase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Psoriatic Arthritis, Axial Spondyloarthritis
RecruitingObservational study
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Rheumatic Diseases, Lupus Erythematosus, Systemic
RecruitingObservational study
Identification of Serum Level of Glutathione Peroxidase 4
Spondyloarthropathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jane Carter study director
Royal United Hospitals Bath NHS FT
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Manual spinal mobilisation physiotherapy in people with Axial Spondyloarthritis, run by Royal United Hospitals Bath NHS Foundation Trust at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of Spinal Mobility (time frame: baseline, 6 months, and follow-up at 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2024.